title: Outcomes-based access: what will it mean for biologics?
abstract: The AMCP Format for Formulary Submissions - driven by OBA principles - has become the standard for big pharma. Now, managed care organizations are applying similar standards to biologic therapies. What manufactures can do to help to ensure acceptance of their products with third-party payers.
authors: Rachel M
authors: RM
authors: Renshaw